Why Africa – and the World – Remain Dangerously Unprepared for the Next Pandemic
The WHO’s Global Preparedness Monitoring Board released its 2026 "A World on the Edge" report amid a fresh Ebola outbreak in the Democratic Republic of Congo, which the WHO declared a public health emergency of international concern. The report finds that global investment in pandemic preparedness still lags far behind the rising risk, and most of its recommendations remain unimplemented, especially across African nations. It calls for independent risk monitoring, health‑workforce retention, equitable access to vaccines and diagnostics, sustainable financing, and continuous political focus. Africa’s own institutions, such as WHO‑Africa and the Africa CDC, must lead these efforts.
Development of a Clinical Prediction Model for Parenteral Nutrition-Associated Cholestasis in Preterm Infants: A Retrospective Cohort Study
A retrospective cohort of 329 preterm infants identified three independent predictors of parenteral nutrition‑associated cholestasis (PNAC): birth weight ≤1,375 g, hemodynamically significant patent ductus arteriosus, and maximum daily parenteral amino‑acid intake ≥4.01 g/kg/day. The multivariable model achieved an area under the ROC...
Feds Release Highly Anticipated No Surprises Act Final Rule, Drawing Mixed Reactions From Radiology
The Centers for Medicare & Medicaid Services issued the final No Surprises Act rule, overhauling the independent dispute resolution (IDR) process. Key changes include a drastic cut to the administrative fee—from $115 to $15 per party—new communication coding requirements, documented...
AstraZeneca Receives the US FDA Approval for Imfinzi Regimen to Treat High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
AstraZeneca’s Imfinzi (durvalumab) combined with Bacillus Calmette‑Guérin (BCG) therapy received U.S. FDA approval for treating adults with BCG‑naïve, high‑risk non‑muscle‑invasive bladder cancer (NMIBC). The decision rests on the phase‑III POTOMAC trial, which enrolled 1,018 patients post‑TURBT and compared Imfinzi + BCG induction...
Effect of Percutaneous Acupoint Electrical Stimulation Combined with Nutritional Support on Gastrointestinal Function and Nutritional Status of Patients After Unicondylar...
A randomized controlled trial of 60 unicondylar knee arthroplasty patients found that adding percutaneous acupoint electrical stimulation to standard postoperative care and conventional nutritional support markedly accelerated gastrointestinal recovery and improved nutritional biomarkers. The experimental group achieved an 86.7% overall...
![AMA: Healthcare 2026: [Interview] A New Way to Fix Lumpectomy Deformities](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://3dprintingindustry.com/wp-content/uploads/2026/05/AMAHealthcare-2026-.png)
AMA: Healthcare 2026: [Interview] A New Way to Fix Lumpectomy Deformities
GenesisTissue is developing a personalized, biodegradable breast tissue scaffold (RBT) that can be 3D‑printed to fill lumpectomy defects and support fat grafts. The scaffold maintains shape for three to six months, then fully degrades within a year, leaving regenerated adipose...
Psychedelic-Assisted Therapies Get a Boost, but Systems Struggle to Play Catch-Up
Psychedelic‑assisted therapy is gaining momentum as several biopharma firms report Phase‑III successes, while President Trump’s executive order earmarks $50 million to speed research. Compass Pathways saw its market value rise about 30% after the order, and companies such as Definium and...
Philips Partners with Disney to Incorporate Iconic Characters in MRI Exams
Philips announced a partnership with the Walt Disney Company to embed Disney characters and stories into its Ambient Experience platform for MRI exams. The Disney‑themed content will launch in 87 countries, aiming to calm pediatric patients during scans. Philips cites...
Some Minorities More Likely to Have Dementia but Less Apt to Signal so on PET Imaging
A new Vanderbilt‑led study of 5,800 Medicare beneficiaries with cognitive impairment found that Black and Hispanic patients are significantly less likely to show amyloid plaques on PET scans, despite higher overall dementia risk. The analysis revealed a 28% lower odds...
Pfizer Signs Potential $10.5bn Oncology Licencing Deal with China’s Innovent
Pfizer has signed a global licensing agreement with China’s Innovent Biologics to co‑develop and co‑commercialize up to 12 oncology drug candidates. The deal includes an upfront payment of $650 million and could total $10.5 billion over its life. Innovent will receive co‑commercialisation...
North Ayrshire Launches New Home Care Digital Platform
North Ayrshire Health and Social Care Partnership has partnered with Totalmobile to roll out the Field First digital platform for its home‑care services. The system will support more than 2,000 residents and coordinate roughly 36,000 weekly visits. Over the next...
Immunai, AstraZeneca Expand Partnership, Rancho Biosciences Releases Multi-Omics Datasets, Dotmatics AI Co-Scientist
Immunai is expanding its partnership with AstraZeneca, securing up to $37.5 million for 2026‑27 to apply its AMICA‑OS AI platform to oncology drug development. Rancho BioSciences launched OmicsHQ, a curated catalog of over 1,000 single‑cell multi‑omics datasets aimed at accelerating AI‑driven...
Teal Health and WashU School of Medicine Partner to Launch Cervical Cancer Screening Pilot
Teal Health, a virtual women’s health company, has launched a research partnership with Washington University School of Medicine to pilot at‑home HPV self‑collection kits for cervical cancer screening. The pilot, run through the SCORE Initiative at Siteman Cancer Center, will...
How APAC Should Deploy AI to Find Hidden Lung Cancers
AI is moving from pilot projects to routine use in several APAC markets, including Malaysia, Indonesia, Vietnam and the Philippines, as health systems grapple with limited CT capacity and radiology shortages. Qure.ai’s chief medical officer highlights that one‑third of lung‑cancer...
![[Comment] Advancing Tau-PET Imaging in Alzheimer's Disease](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/d7dfbf5e1c7160c8f2aa1fa113274d6e.webp)
[Comment] Advancing Tau-PET Imaging in Alzheimer's Disease
The Lancet commentary highlights how tau‑PET imaging has moved from a research novelty to a cornerstone of Alzheimer’s disease diagnosis and drug development. Over the past decade, radioligands such as [18F]flortaucipir have become essential inclusion criteria and outcome measures in...
![[Comment] Offline: The Dishonest Politics of Global Health](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/43c18925e9387aaa45d34e13dcfde489.webp)
[Comment] Offline: The Dishonest Politics of Global Health
The World Health Assembly was dominated by the fresh Ebola outbreak in the Democratic Republic of Congo, where a 23‑day gap between case detection and the WHO’s Public Health Emergency declaration highlighted chronic surveillance failures. Delegates also debated a new...
![[Comment] Prasinezumab: What Have We Learned From PASADENA and PADOVA?](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/f31e0b4ec0510b45a35ec13b633c65e2.webp)
[Comment] Prasinezumab: What Have We Learned From PASADENA and PADOVA?
Prasinezumab, an antibody targeting aggregated α‑synuclein, was tested in the phase‑2 PASADENA trial in early‑stage Parkinson's patients. The study failed to meet its primary endpoint—change in the combined MDS‑UPDRS I‑III score after 52 weeks—though the low‑dose arm showed modest improvement...
![[Comment] Multi-Arm Multi-Stage Platform Trials for Neurological Disease: Accelerating Progress](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/c5e0887cefc9d7a6210ea0a37fc55823.webp)
[Comment] Multi-Arm Multi-Stage Platform Trials for Neurological Disease: Accelerating Progress
The Lancet commentary highlights multi‑arm multi‑stage (MAMS) platform trials as a solution to the sluggish pace of neurodegenerative drug development. By testing several mechanistically‑selected candidates within a single adaptive protocol, researchers can reach definitive phase‑3 conclusions faster. The piece cites...
Preventing Stunting — Lessons From a Western Cape Maternal Health Pilot
Rising food insecurity has left 17.5% of Western Cape children under five stunted, threatening cognitive development and long‑term health. In response, the Western Cape Government, DG Murray Trust, Shoprite and Grow Great launched the Khulisa Care pilot, a cash‑plus‑care model...
AHA Files Amicus Brief in Appeals Court Supporting Dismissal of Online Tracking Case
The American Hospital Association (AHA) filed an amicus brief in the 7th U.S. Circuit Court of Appeals urging dismissal of an online‑tracking lawsuit against a member hospital. Plaintiffs claim the provider improperly disclosed protected health information to a third‑party website,...
CMS Releases Final Rule on Updates to No Surprises Act Independent Dispute Resolution Process
On May 28, 2026 the Departments of Health and Human Services, Labor and Treasury issued a final rule to improve the No Surprises Act independent dispute resolution (IDR) process. The rule streamlines communication among payers, providers and certified IDR entities,...
CMS Finalizes Rule to Simplify Payer-Provider Disputes Under No Surprises Act
The Centers for Medicare & Medicaid Services (CMS) finalized a rule on Thursday to overhaul the independent dispute resolution (IDR) process created by the No Surprises Act. The rule slashes the administrative fee from $115 to $15 per party and...
$2M NIH Award Spurs Development of Advanced Ultrasound Technique
Researchers at the University of Texas at Arlington have secured a roughly $1.7 million NIH grant to advance ultrasound imaging that can see deep‑tissue blood vessels. Over the next four years the team will fuse ultrasound with external light and engineered...
VRBPAC Chooses Strain For COVID-19 Vaccine Targeting, Not In Agreement With WHO
The FDA’s Vaccine and Related Biological Products Advisory Committee (VRBPAC) voted on May 28 to recommend that the 2026‑2027 COVID‑19 vaccine target the currently dominant XFG variant. This recommendation diverges from the World Health Organization’s advice, which continues to endorse...
AARP Urges Congress To Quickly Address Social Security, Medicare Solvency
AARP is urging Congress to act swiftly on the looming financing gaps in Social Security and Medicare before the programs’ 2026 trustees report. The organization warns that rising health‑care expenses and cost‑of‑living pressures are already straining older Americans. Delaying reforms...
Ōura to Add Blood Pressure Feature Following FDA Policy Change
Ōura introduced the Ring 5 smart ring and announced a suite of new health features to roll out in June. The updates include nighttime blood‑pressure trend monitoring, which reports pressure patterns without systolic/diastolic numbers, and a 30‑day view of breathing regularity....
Widow Donates $1M to Hospital for Permanent PET Scanner in Late Husband's Honor
Carole Bloodgood has pledged a $1 million gift to Hancock Health’s foundation to fund a permanent PET/CT scanner, honoring her late husband Tom. The hospital currently relies on a mobile PET unit that visits only once a week, creating bottlenecks as...
US Healthcare Still Stupidly Expensive, with Pathetic Outcomes, Study Finds
The Commonwealth Fund’s 2024 analysis of 20 health systems finds the United States a persistent failure, spending far more while delivering poorer outcomes. The U.S. devoted 18% of its GDP to health care—nearly twice the 9.3% average of peer nations—and...
Healthcare Raises the Bar on Medical Device Security, But Vulnerabilities Remain
Healthcare providers are embedding cybersecurity criteria into medical‑device procurement, with 84% now requiring security clauses in RFPs. Yet attacks rose, as RunSafe Security’s 2026 Index shows 24% of organizations faced device‑related cyber incidents, 80% of which disrupted patient care. Legacy...
Historical Information on REMS for Opioid Analgesics
The U.S. Food and Drug Administration has built a class‑wide Risk Evaluation and Mitigation Strategy (REMS) for opioid analgesics through a series of actions spanning 2010‑2017. Early advisory committee meetings in 2010 set the groundwork, leading to mandatory safety measures...
Siemens Healthineers, AiM Team up; Procept Completes Study Enrollment
Siemens Healthineers and AiM Medical Robotics announced a collaboration to integrate AiM’s portable robotic neurosurgery platform with Siemens’ Magnetom MRI scanners, enabling MRI‑guided procedures such as deep‑brain stimulation and tumor ablation. AiM, which raised $8.1 million in a Series A round last...
How Framework Modernization Benefits Public Health Data Exchange
Eric Larson, senior health‑IT lead at AIRA, highlighted how adopting the FHIR standard for immunization registries streamlines data queries for clinicians and gives patients direct, mobile access to their vaccination records. The move replaces fragmented legacy interfaces with a unified...
This Biotech Is Leading What Could Be a 'GLP-1 Moment for Hair Loss,' Says BTIG
Absci Corporation’s AI‑designed antibody ABS‑201 is entering Phase 1/2A trials for androgenetic alopecia, a market of roughly 80 million Americans. BTIG upgraded coverage to a buy with a $9 price target, forecasting up to $2.2 billion in peak sales and likening the drug...
There Are No ‘Perfect Decisions’ with Healthcare: Virta Health CFO
Healthcare costs are soaring, driven by inflation and pricey new drug classes like GLP‑1 therapies that can exceed $1,000 a month. Virta Health CFO Manu Diwakar says CFOs must first define a total cost envelope—per‑employee or overall—and then decide how...
HCA Texas Hospital Taps COO
HCA Houston Healthcare Northwest announced the appointment of Angela Dillon as chief operating officer, effective May 18. Dillon joins from Sunrise Hospital & Children’s in Las Vegas, where she was vice president of operations and co‑ethics compliance officer. She previously served as associate...
Target for Aggressive Prostate Cancer Prevention Identified in Mice
Columbia University researchers identified SIRT1 as a driver of neuroendocrine prostate cancer (NEPC) in mice. Using a Sleeping Beauty forward genetic screen, they pinpointed SIRT1 among 75 candidate genes and showed that silencing or pharmacologically inhibiting it dramatically reduced tumor...
Immunization Reporting Gets a Shot in the Arm From Interop Efforts
Eric Larson, senior health‑IT lead at the American Immunization Registry Association, says new interoperability initiatives are streamlining the flow of vaccination data among electronic health records, pharmacies and state registries. By leveraging standardized APIs and FHIR resources, clinicians can now...
Novant Health Buys South Carolina Land to Build $25M Medical Hub
Novant Health, headquartered in Winston‑Salem, N.C., completed a $4.34 million purchase of a former automotive site in Hilton Head, S.C., to build a $25.3 million, 25,000‑square‑foot medical hub. The campus will host primary care, physical therapy and urology services, adding 15,000 sq ft of...
American Heart Association Takes on Cardiac Amyloidosis with New Initiative
The American Heart Association (AHA) has launched a national clinical initiative to raise awareness of cardiac amyloidosis and standardize early, non‑biopsy diagnosis. The program targets cardiologists, imaging specialists, hematologists and primary‑care providers, promoting a diagnostic algorithm that combines nuclear scintigraphy...
AbbVie’s ADC Strategy Notches Another Win With FDA Approval in Ultra-Rare Blood Cancer
AbbVie secured FDA approval for Decnupaz (pivekimab sunirine), an antibody‑drug conjugate that targets CD123 in blastic plasmacytoid dendritic cell neoplasm (BPDCN), an ultra‑rare aggressive blood cancer. In a Phase 1/2 trial, 69.7% of treatment‑naïve patients achieved complete or clinical remission, while...
Vaccine Shows Promise Against Aggressive Brain Cancer
A phase‑1 trial of Geneos Therapeutics' DNA‑based vaccine GNOS‑PV01 at Washington University’s Siteman Cancer Center demonstrated safety and a survival advantage in patients with aggressive glioblastoma. The personalized vaccine, which encodes up to 40 tumor‑specific neoantigens, showed no serious adverse...
Insilico Medicine, Human Longevity Partner for Longevity Foundation Model
Insilico Medicine and Human Longevity have formed Human Life Foundation Models, Inc., a joint venture to build large‑scale AI foundation models for longevity science. Backed by a multi‑year, multi‑million‑dollar framework, the effort will leverage Human Longevity’s extensive multimodal health dataset...
6 Healthcare Leaders Named to Fortune’s Most Powerful Women List
Fortune’s 2026 Most Powerful Women list highlighted six senior women in healthcare, including two health‑insurance CEOs. The rankings, released May 27, span 100 leaders across 94 companies worldwide and assess size, innovation, influence, trajectory and impact. Vertex Pharmaceuticals’ Reshma Kewalramani...
Have Clinicians Been Wrong About How They Diagnose PAD?
A new JACC study of 225,000 U.S. veterans shows that ankle‑brachial index values of 0.91‑1.00, previously called “borderline,” are linked to higher rates of major adverse limb events, amputations and revascularization than normal ABI. The risk elevation holds across gender...
News Briefs: CMS Proposes a Modest Increase to Hospital Inpatient Payments for FY27
The Centers for Medicare & Medicaid Services (CMS) has proposed a 2.4% increase in the average Medicare inpatient payment for FY27, translating to roughly $1.4 billion industry‑wide. After accounting for quality‑data, EHR‑use adjustments and a mandatory productivity cut, the net rise...
Antiseptic Meetings
The Over-the-Counter Monograph Safety, Innovation, and Reform Act was signed into law on March 27, 2020, aiming to modernize FDA regulation of OTC monograph drugs. Since then, the FDA has held a series of technical meetings with industry groups such...
Untreated MASH With T2D to Drive Costs 5-Fold: Zobair Younossi, MD
Metabolic dysfunction‑associated steatohepatitis (MASH) combined with type 2 diabetes is projected to cost the U.S. health system nearly five times more by 2040 if current practices persist. Although FDA‑approved therapies exist, primary‑care and endocrinology settings still stratify very few patients, leaving...
When Nurses Shape the Technology, Patients Feel the Difference
University Health Kansas City, led by chief nursing officer Amy McTaggart, partnered with Philips to replace fragmented digital tools with a centralized monitoring hub. The integration cut non‑actionable alarms by 22% and reduced waveform‑strip documentation time by 69.6%, saving more...
Teladoc Adds Virtual Care Services to Walmart Digital Health Platform
Teladoc Health announced a partnership with Walmart to embed its virtual care services—urgent care, dermatology and nutrition support—into Walmart’s Better Care Services platform. The integration lets consumers access 24/7 urgent care for a cash price of $89 per visit, alongside...
Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS)
The FDA’s Opioid Analgesic Risk Evaluation and Mitigation Strategy (OA REMS) now includes a modification authorizing manufacturers to supply pre‑paid mail‑back envelopes (MBEs) for safe disposal of outpatient opioid prescriptions, effective March 31 2025. The change complements the OA REMS education program, which provides...